The Neuropsychology of Schizophrenia Circa 2009 by Bilder, Robert M.
EDITORIAL
The Neuropsychology of Schizophrenia Circa 2009
Robert M. Bilder
Received: 24 July 2009 /Accepted: 29 July 2009 /Published online: 13 August 2009
# The Author(s) 2009. This article is published with open access at Springerlink.com
Keywords Neuropsychology.Cognitive neuroscience.
Genetics.Informatics.Neuroimaging.Phenomics.
Schizophrenia
The last 30 years have been marked by the emergence of
transformative technologies for the study of brain structure-
function relations, and these have been deployed vigorously
to help unravel the mysterious causes for, and treatments
for the schizophrenia syndrome. Despite the progress, the
ultimate goal—to identify a “smoking gun,” in the form of
a cognitive, a functional anatomical or a genetic signature
responsible for the brain pathology underlying schizophre-
nia—remains elusive. This collection of articles from global
leaders in neuropsychological research on schizophrenia
makes poignant how much our thinking has changed over
the last three decades, but also that we still have more
questions than answers about the fundamental neurobio-
logical underpinnings of schizophrenia.
To put the progress in perspective, we may recall the
conclusions of Heaton et al. (1978), following their
incisive review of neuropsychological studies of psychiatric
disorders:
“The finding that chronic or process schizophrenics
look like organics on neuropsychological tests might
be considered surprising … One fairly popular
explanation … is that … motivational deficiencies
and thought disorders are responsible … the implica-
tion is that these deficits are functional in nature. This
explanation cannot be ruled out on the basis of
currently available evidence, but it can be questioned”
(page 156); and “[it is likely that] chronic schizo-
phrenics will appear organic on neuropsychological
testing because a significant proportion of them are
organic” (page 157).
These prescient (and diplomatic) statements signal what
was then a prevalent dualistic perspective, the echoes of
which are now only faint. For example, one may note that
the term “organic” was effectively scrubbed from the
DSM-IV, contrasting to its conspicuous presence in the
DSM-III. If the 21st century is one day seen as marking
the death of dualism in psychiatric taxonomies, this may
be considered a victory for neuropsychology, neuroimag-
ing (which provided compelling evidence of structural
brain anomalies (Johnstone et al. 1976)), and genetics
(confirming heritability of ~80% for the schizophrenia
syndrome). Whatever the driving forces, it is now com-
monplace to seek biological explanations for both the
causes and treatments of schizophrenia, and this reflects a
sea change in thinking for which neuropsychology can
claim significant credit.
The reviews in this issue offer snapshots from multiple
perspectives embraced in 21st century research on the
neuropsychology of schizophrenia. These papers show that
neuropsychology has become central to the study of both
the causes and treatments of schizophrenia.
& Palmer, Dawes, and Heaton offer a broad historical
view, highlighting the role neuropsychological research
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schizophrenia. These studies have generated solid
consensus about the severity, pattern, and typical course
of deficits. Perhaps most important has been apprecia-
tion of the impact of these deficits on outcomes, leading
to the view that cognitive impairments are indeed more
important than the symptoms now used to diagnose the
disorder, both to advance understanding of pathophys-
iology and to target for effective treatment.
& Corresponding to the increased appreciation that cogni-
tive deficits are central to schizophrenia, research on
neuropsychological consequences of treatment has
expanded dramatically. Harvey provides an incisive
survey of psychopharmacological strategies that have
been tried so far, and some that remain on the horizon.
Following what might be described as excessive (if not
“irrational”) exuberance over the cognitive gains seen in
early studies of the “atypical” antipsychotics, steady
progress has been made laying the groundwork for
systematic efforts to both identify agents capable of
modifying cognition in schizophrenia, and facilitate
investigation of these agents using consensus methods
(e.g., as accomplished by the MATRICS and TURNS
initiatives).
& Stimulated in part by disappointment over the lack of
efficacy and effectiveness of new psychopharmacolog-
ical treatments, the last decade also has witnessed a
surge of interest in non-pharmacological strategies to
treat cognitive deficits in schizophrenia. Medalia and
Choi provide an important perspective on the matura-
tion of cognitive remediation research in schizophrenia,
highlighting what are now appreciated as consistent
moderate effects (which are greater than observed for
any drug treatments so far), and emerging consensus
regarding the critical mediators and moderators of these
treatments.
& One clear mark of the maturation of neuropsychological
research on schizophrenia is the increased emphasis on
identification of its developmental precursors, with an
eye towards development of early intervention or even
prevention strategies. Two unique perspectives on these
issues are provided here (Pantelis et al.; Niendam et al.).
Pantelis et al. survey the results of neuropsychological
and neuroimaging findings in individuals at high risk
for later development of schizophrenia, and while there
are promising leads, they conclude that further work
focused on the dynamic, longitudinal patterns of change
in these indicators may be necessary going forward.
Niendam et al. offer a compatible perspective, but
highlight the critical importance of understanding both
social outcomes, and social cognitive predictors of these
outcomes, to gain a stronger appreciation of the
prodromal state and to aid in the design of optimal
intervention or prevention strategies.
& Palmer et al. note that despite progress, there remains
no consensus about the fundamental pathophysiological
processes involved in schizophrenia at either neural
systems or cognitive levels. Three integrative reviews
illustrate current thinking about these grand challenges.
Starting from the rational premise that episodic memory
deficits have emerged as the most consistent and robust
markers of schizophrenia, Leavitt and Goldberg
critically evaluate the relevant neuroanatomical, genetic,
and behavioral evidence. They conclude that integrative
strategies, including advanced computational modeling
together with functional neuroimaging, may help
advance clearer mechanistic models of the memory
dysfunction that is already a well validated marker of
disability. Krauss, Keefe, and Krishnan present a
highly innovative perspective that aims to offer a
unified theory through which a common mechanism,
based on memory prediction errors, may help under-
stand not only why “memory deficits” are so prominent,
but also why people with schizophrenia suffer from a
range of other symptoms, including disorders of
perceptual processing. Such a perspective might help
significantly reorient thinking about the memory fail-
ures of schizophrenia, and other signs, with respect to
specific deficits in neuronal architecture, and more
specific basic cognitive mechanisms underlying anoma-
lies in extracting and utilizing regularities of prior
experience. Finally, the contribution of Gold, Hahn,
Strauss & Waltz really does aim to “turn it upside
down” and ask what we can learn from what is not
impaired in people with schizophrenia. While some
might see the search for the holy grail of a specific
deficit in schizophrenia as having met with abject
failure, and adopted instead a generalized deficit model,
there are clearly areas of cognitive performance that
may, by virtue of their preservation, point us towards
both clearer understanding of pathological processes (in
part by ruling out certain possibilities), and further
highlight potential targets for remediation based on
preserved functions.
While these studies provide an enormous breadth and
depth of coverage, no collection of papers can reflect the
complete spectrum of current thinking about the neuropsy-
chology of schizophrenia nor predict well what the “next
big thing” may be. Recent genome-wide association studies
have highlighted what is likely to be greater complexity of
schizophrenia genetics than was previously anticipated,
278 Neuropsychol Rev (2009) 19:277–279with thousands of common alleles each having small
contributions to risk for both schizophrenia and bipolar
disorder (The International Schizophrenia Consortium
2009). It is now also clearer that a broad collection of
“generalist” genes likely explain the heritability of diverse
cognitive traits (Butcher et al. 2006). These observations
suggest that neuropsychology research is primed to move
beyond the custom of studying cognitive domains that were
originally validated with respect to discrete brain lesions,
and begin to redefine neuropsychological constructs with
respect to distributed neural systems functions, cellular
systems and signaling pathways, and molecular variations
(Bilder et al. 2009b, c; Sabb et al. 2009).
Neuropsychology research and practice are further
poised to capitalize on the revolution in information
technology. Not long ago it would be reasonable to believe
that the “wisdom of crowds” was an obvious oxymoron.
But the success of Wikipedia and other social collaborative
networking applications have made it clear that large
numbers of individuals can generate novel intellectual
products with high utility. Some applications already enable
collaborative knowledge-base development for cognitive
phenotypes, linking hypotheses about cognitive concepts to
the empirical data on which these hypotheses are based
(Bilder et al. 2009a, b, c; Sabb et al. 2008), and a new
Society for Neuroinformatics in Neuropsychology has just
been established (see http://www.scnn.org/). There is
further hope that similar efforts can bear fruit for clinical
neuropsychology, by establishing collaborative databases
and developing open-access assessment instruments. These
strategies may one day overcome some of the limitations of
laboratory- and clinic-based methods, and enable knowl-
edge to be accumulated from much larger communities,
substantially complementing and extending current meth-
ods. Working together with patient-oriented networks, there
is hope that in another three decades, a special issue on the
neuropsychology of schizophrenia will have answers to
many of our current questions, and that previously
unimaginable enigmata will have replaced those that we
confront today.
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